196 results Key considerations for management and owners of Dutch privately held companies in distress due to COVID-19 The COVID-19 pandemic has a significant and immediate adverse effect on many companies in different industries. Many PE portfolio companies are particularly vulnerable given the typical high leverage finance structure and inherent need to maintain cash fl Daisy Nijkamp and Job van Hooff present webinar on The Dutch scheme (WHOA) – the upcoming new Dutch restructuring tool Daisy Nijkamp and Job van Hooff, in collaboration with Lexology, will present a webinar on WHOA on 2 April 2020. During the webinar they will look at a new bill prepared by the Dutch legislature - the Act on the Confirmation of Private Restructuring Plans Onzeker ondernemingsrecht – het coronavirus and beyond It is a world of change in which we live, and a world of uncertainty” Het bovenstaande citaat is van de Amerikaanse econoom Frank H. Knight en afkomstig uit zijn in 1921 verschenen boek.1 Knight beschrijft daarin wat het belang is van het concept “onzek Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions. Rechtsmacht bij pauliana: Feniks-arrest leidt tot onvoorzienbaarheid In het arrest Feniks van 4 oktober 2018 heeft het Europees Hof van Justitie meer duidelijkheid geschapen over de vraag welke rechter internationaal bevoegd is in geval van een actio pauliana. The Dutch Scheme – high flexibility in plan contents and possibility to affect group guarantees The Act on confirmation of private restructuring plans – which introduces a framework allowing debtors to restructure their debts outside formal insolvency proceedings (the “Dutch Scheme“) – was adopted by the Dutch Senate on 6 October 2020. Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Cease fire on troubled companies! Royal Decree temporarily suspends enforcement Royal Decree No. 15 introduces a temporary moratorium amid COVID-19, shielding debtor-companies from enforcement measures and bankruptcy declarations. Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL). Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Stibbe advises Proximus Stibbe advised Proximus, a listed company and longstanding client, on a broad variety of matters, including innovative partnerships, regulatory compliance, M&A and finance projects, and dispute resolution. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Frigoglass Stibbe advises Frigoglass on the completion of its restructuring proces Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises Nyobe NV Stibbe assisted Nyobe NV with its judicial reorganisation procedure with a view of transferring Nyobe’s activities under the court’s supervision, after Nyobe was confronted with a fiscal claim of 100 million euro. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Pagination Previous page Page 5 Current page 6 Page 7 Page 8 Next page
Key considerations for management and owners of Dutch privately held companies in distress due to COVID-19 The COVID-19 pandemic has a significant and immediate adverse effect on many companies in different industries. Many PE portfolio companies are particularly vulnerable given the typical high leverage finance structure and inherent need to maintain cash fl
Daisy Nijkamp and Job van Hooff present webinar on The Dutch scheme (WHOA) – the upcoming new Dutch restructuring tool Daisy Nijkamp and Job van Hooff, in collaboration with Lexology, will present a webinar on WHOA on 2 April 2020. During the webinar they will look at a new bill prepared by the Dutch legislature - the Act on the Confirmation of Private Restructuring Plans
Onzeker ondernemingsrecht – het coronavirus and beyond It is a world of change in which we live, and a world of uncertainty” Het bovenstaande citaat is van de Amerikaanse econoom Frank H. Knight en afkomstig uit zijn in 1921 verschenen boek.1 Knight beschrijft daarin wat het belang is van het concept “onzek
Contracts & Corona: force majeure and related topics The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.
Rechtsmacht bij pauliana: Feniks-arrest leidt tot onvoorzienbaarheid In het arrest Feniks van 4 oktober 2018 heeft het Europees Hof van Justitie meer duidelijkheid geschapen over de vraag welke rechter internationaal bevoegd is in geval van een actio pauliana.
The Dutch Scheme – high flexibility in plan contents and possibility to affect group guarantees The Act on confirmation of private restructuring plans – which introduces a framework allowing debtors to restructure their debts outside formal insolvency proceedings (the “Dutch Scheme“) – was adopted by the Dutch Senate on 6 October 2020.
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Cease fire on troubled companies! Royal Decree temporarily suspends enforcement Royal Decree No. 15 introduces a temporary moratorium amid COVID-19, shielding debtor-companies from enforcement measures and bankruptcy declarations.
Stibbe advises Aedifica Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL).
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Stibbe advises Proximus Stibbe advised Proximus, a listed company and longstanding client, on a broad variety of matters, including innovative partnerships, regulatory compliance, M&A and finance projects, and dispute resolution.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises Nyobe NV Stibbe assisted Nyobe NV with its judicial reorganisation procedure with a view of transferring Nyobe’s activities under the court’s supervision, after Nyobe was confronted with a fiscal claim of 100 million euro.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").